Bharat Biotech to resume exports of Covaxin

• On Monday, COVID-19 vaccine-maker Bharat Biotech announced that the company has resumed the export of its COVID-19 vaccine Covaxin.

• The company will start exporting in December 2021.

• Covaxin is 78% effective against severe cases of COVID-19.